Navigation Links
The Effectiveness Of The Breast Cancer Drug By Pfizer

Pfizer has increased the survival rate of breast cancer patients by 63 percent with their latest drug compared to the standard regimes available . The clinical trial strengthens the case for administering the newer drug, exemestane, as a first option.// A study showed that women recovering from breast cancer lowered their chance of developing another tumor by 32 percent if they switched to exemestane after two or three years of tamoxifen treatment.

According to the research presented this week at a breast cancer conference , the median survival for patients taking exemestane was 10.9 months, compared with 6.7 months for patients on tamoxifen. About 44.2 percent of patients in the study had tumors that responded either partially or fully to exemestane , compared with 29.2 percent on tamoxifen. The difference was statistically significant. These reports have been substantiated by specialists in the field who began trying the drug in patients in 1989, well before it was approved.

Tamoxifen is sold under the brand name Nolvadex by AstraZeneca Plc and is usually taken for five years. Tamoxifen works by blocking the hormone estrogen, which can stimulate and feed the growth of breast cancer.

By contrast, exemestane was the first approved oral therapy that binds to an enzyme known as aromatase, which normally converts the hormone androgen into estrogen in postmenopausal women. The drug thereby curtails the actual supply of estrogen to the cancerous tumors that are dependent on it, rather than blocking estrogen after it is already produced. Pfizer markets exemestane under the brand name Aromasin.

Researchers say ,"These (studies) are pieces of the puzzle, and the puzzle is becoming clearer now."
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. The Effectiveness Of Screening Tests Questioned
3. The Effectiveness Of Chickenpox Vaccine Questioned
4. The Effectiveness Of Antibacterial Products In Reducing Infection
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. Effectiveness Of Prostate Cancer Test
7. Studying The Effectiveness Of Cough Syrups
8. The Effectiveness Of NSAIDs Evaluated
9. Effectiveness Of Infertility Treatments Questioned
10. Report on the Safety and Effectiveness of Melatonin supplements
11. The Effectiveness Of Inhaled Corticosteroids Studied
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 2016 , ... TherapySites, the leading website and ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to extend ... exclusive benefits and promotional offers. , "TCA is extremely excited about this new ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: